Farallon Capital Management »

Altimmune shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.8M 470k 10.18

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Pioneer Natural Resources (PXD)
UnitedHealth (UNH)
Iqvia Holdings (IQV)
Exelixis (EXEL)
salesforce (CRM)
Aramark Hldgs (ARMK)
Nasdaq Omx (NDAQ)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Transunion (TRU)
New York Times Cl A (NYT)
Ishares Tr Ishares Biotech Put Option (IBB)
Thermo Fisher Scientific (TMO)
Wabtec Corporation (WAB)

View all positions for Farallon Capital Management

Top funds holding Altimmune

State Street Corporation
BlackRock
Vanguard Group
Tang Capital Management
Morgan Stanley
Susquehanna International
Ameriprise Financial
Millennium Management
Geode Capital Management
Fred Alger Management
Nuveen Asset Management
Portolan Capital Management
Rafferty Asset Management
Goldman Sachs Group
Readystate Asset Management

View all funds holding Altimmune